Literature DB >> 10504480

Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury.

G Gobé1, D Willgoss, N Hogg, E Schoch, Z Endre.   

Abstract

A major contributor to the development and progression of ischemia-reperfusion (IR)-induced acute renal failure (ARF) is the loss of functioning tubular epithelial cells by means of various cell deletion or death processes. Although the term "acute tubular necrosis" is still used to describe the pathology of ARF, this is a misnomer because apoptotic cell death, as well as necrosis, occurs [1, 2] along with desquamation and loss of viable epithelial cells [3]. Apoptosis was first described in renal disease in 1987 in an animal model of hydronephrosis [4]. In ARF, with reference to only the death processes, the relative contribution of necrosis or apoptosis possibly depends on the extent of the initiating events. For example, after prolonged total renal ischemia, necrosis or "accidental cell death" occurs from the resultant negation of the cell's energy and protein levels. In apoptosis, the cells use their own energy processes and proteins to die, and often the initiating ischemia is more mild [5]. Finally, despite prolonged ischemia, within the heterogeneous renal cell populations there are those that are more sensitive to ischemia, such as the proximal straight tubule and to some extent the thick ascending limb (TAL) of the loop of Henle. It may be hypothesized that these cells tend to undergo necrosis in comparison with the less sensitive segments that undergo apoptosis. Because apoptosis is gene driven, its identification is important because of the possibility of its modulation via molecular controls. However, despite these new concepts of ARF, patient death remains high, at approximately 30 to 50% of ARF cases. Recovery from ARF depends not only on the replacement or regeneration of cells deleted by death, the theme of many recent studies, but also on protection of cells from death. Both processes are dependent on many of the cellular and molecular controls that have evolved in multicellular organisms to manage normal development, differentiation and growth processes, but that then become involved in the pathogenesis and progression of many renal diseases, including ARF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504480     DOI: 10.1046/j.1523-1755.1999.00701.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4.

Authors:  Jianlin Chen; John R Hartono; Reji John; Michael Bennett; Xin Jin Zhou; Yanxia Wang; Qingqing Wu; Pamela D Winterberg; Glenn T Nagami; Christopher Y Lu
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

2.  The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.

Authors:  Akosua Vilaysane; Justin Chun; Mark E Seamone; Wenjie Wang; Rick Chin; Simon Hirota; Yan Li; Sharon A Clark; Jurg Tschopp; Kiril Trpkov; Brenda R Hemmelgarn; Paul L Beck; Daniel A Muruve
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

3.  Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.

Authors:  Akihisa Matsuda; Rongqian Wu; Asha Jacob; Hidefumi Komura; Mian Zhou; Zhimin Wang; Md Monowar Aziz; Ping Wang
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

4.  Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption.

Authors:  Neeraj Sharma; Erik B Malarkey; Nicolas F Berbari; Amber K O'Connor; Gregory B Vanden Heuvel; Michal Mrug; Bradley K Yoder
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

5.  Hematopoietic stem cells derived from human umbilical cord ameliorate cisplatin-induced acute renal failure in rats.

Authors:  Rokaya H Shalaby; Laila A Rashed; Alaa E Ismaail; Naglaa K Madkour; Sherien H Elwakeel
Journal:  Am J Stem Cells       Date:  2014-09-05

6.  Ghrelin-mediated pathway in Apolipoprotein-E deficient mice: a survival system.

Authors:  Rita Rezzani; Caterina Franco; Gaia Favero; Luigi F Rodella
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

7.  Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.

Authors:  S Crikis; B Lu; L M Murray-Segal; C Selan; S C Robson; A J F D'Apice; H H Nandurkar; P J Cowan; K M Dwyer
Journal:  Am J Transplant       Date:  2010-09-14       Impact factor: 8.086

8.  Cardio-renal recovery of hypoxic newborn pigs after 18%, 21% and 100% reoxygenation.

Authors:  Po-Yin Cheung; Laila Obaid; Marwan Emara; Yann Brierley; Scott T Johnson; Grace S Chan; Laurence Jewell; Gregory Korbutt; David L Bigam
Journal:  Intensive Care Med       Date:  2008-01-31       Impact factor: 17.440

9.  Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney.

Authors:  Weiwei Wang; W Brian Reeves; Ganesan Ramesh
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

10.  Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.

Authors:  Mingyi Yao; Natasha M Rogers; Gábor Csányi; Andres I Rodriguez; Mark A Ross; Claudette St Croix; Heather Knupp; Enrico M Novelli; Angus W Thomson; Patrick J Pagano; Jeffrey S Isenberg
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.